标题 |
A triple-masked, primary therapy study of the efficacy and safety of BID and TID-dosed brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% and BID-dosed timolol 0.5%
一项关于BID和TID剂量1.0%布林佐胺与TID剂量2.0%多佐胺和BID剂量0.5%噻吗洛尔的疗效和安全性的三重掩蔽初级治疗研究
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
作者:Camras CB, the Brinzolamide Primary Therapy Study Group. 期刊:Invest Ophthalmol Vis Sci 1997;38(4,suppl):S560. |
求助人 | |
下载 |